Ammonia → HCID 86647870, 화합물
반응식
C([O:5][C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:19]=[CH:18][C:17]([C:20]3[O:24][C:23]([NH:25][C:26]4[CH:27]=[N:28][CH:29]=[CH:30][CH:31]=4)=[N:22][C:21]=3[C:32](O)=[O:33])=[CH:16][CH:15]=2)[CH2:10][CH2:9]1)=[O:7])(C)(C)C.F[P-](F)(F)(F)(F)F.C[N+](C)=C(N(C)C)O.C([N:53](C(C)C)CC)(C)C.N.O1CCOCC1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)[C:77]2N=C[CH:80]=[CH:81][C:76]=2N=N1>CN(C=O)C>[C:32]([C:21]1[N:22]=[C:23]([NH:25][C:26]2[CH:27]=[N:28][CH:29]=[CH:30][CH:31]=2)[O:24][C:20]=1[C:17]1[CH:16]=[CH:15][C:14]([N:11]2[CH2:10][CH2:9][N:8]([C:6]([O:5][CH2:77][CH2:76][CH2:81][CH3:80])=[O:7])[CH2:13][CH2:12]2)=[CH:19][CH:18]=1)(=[O:33])[NH2:53]참가 물질
반응물 6
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 5-(4-(4-(tert-butoxycarbonyl)piperazin-1-yl)phenyl)-2-(pyridin-3-ylamino)oxazole-4-carboxylic acid (0.046 g, 0.1 mmol) in DMF (1 ml) was added O-7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (0.065 g, 0.17 mmol), diisopropylethylamine (0.03 ml, 0.17 mmol) and 0.5M NH3 in dioxane (0.6 ml, 0.3 mmol) and the resultant mixture stirred at room temperature overnight. A further portion of O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (0.020 g, 0.05 mmol), diisopropylethylamine (0.01 ml, 0.056 mmol) and 0.5M NH3 in dioxane (0.2 ml, 0.1 mmol) was added and the reaction stirred for 1 hour. The solvent was removed in vacuo and the residue purified by preparative HPLC to afford tent-butyl 4-(4-(4-carbamoyl-2-(pyridin-3-ylamino)oxazol-5-yl)phenyl)piperazine-1-carboxylate (0.006 g, 0.013 mmol, 13%). LCMS (2) Rt: 2.64 min; m/z (ES+) 465.
후처리
- customThe solvent was removed in vacuo
- customthe residue purified by preparative HPLC
출처 및 근거
- ORD 기록
- ord-4444e8167dde48db8767033618a2e812
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08378095B2
반응 노트
불러오는 중…